Sugi Predict

Sugi Predict / Compounds / SCHEMBL2773479

SCHEMBL2773479

SCHEMBL2773479

COc1cc(F)cc(-c2cc(CN(C)S(=O)(=O)c3ccc(F)c(Cl)c3)ccc2OCC(=O)OC(C)(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.38
▸ ACLY P53396 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ TAS2R14 Q9NYV8 2/20 0.35
▸ TP53 P04637 2/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ PSEN1 P49768 2/20 0.34
▸ PSEN2 P49810 2/20 0.34
▸ APH1B Q8WW43 2/20 0.34
▸ NCSTN Q92542 2/20 0.34
▸ APH1A Q96BI3 2/20 0.34
▸ PSENEN Q9NZ42 2/20 0.34
▸ PTGER2 P43116 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ SOS1 Q07889 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770497 0.90 PTGDR2 (0.44) MAPTPTGDR2PTGER2PTPN1
SCHEMBL2771359 0.90 MAPT (0.41) MAPTACLYALDH1A1KMT2ATAS2R14
SCHEMBL14882613 0.84 MAPT (0.38) MAPTACLYALDH1A1TAS2R14TP53
SCHEMBL2770575 0.84 PTGDR2 (0.47) MAPTTP53PTGDR2PTPN1
SCHEMBL12948709 0.83 ACLY (0.42) MAPTACLYALDH1A1KMT2ATP53
SCHEMBL2770509 0.83 MAPT (0.41) MAPTACLYALDH1A1KMT2ATP53
SCHEMBL2770744 0.82 PTGDR2 (0.45) MAPTTAS2R14PTGDR2PTGER2PTPN1
SCHEMBL2771457 0.81 TAS2R14 (0.47) MAPTTAS2R14PTGDR2PTGER2PTPN1
SCHEMBL13160869 0.80 PTGDR2 (0.44) MAPTTP53PTGDR2LMNARXFP1
SCHEMBL2773052 0.79 PTGDR2 (0.47) MAPTALDH1A1TAS2R14PTGDR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822467-B2 Biaryl oxyacetic acid compounds LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-09-02 — — US disclosed
US-8822467-B2 Biaryl oxyacetic acid compounds LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-09-02 — — US disclosed
US-8822467-B2 Biaryl oxyacetic acid compounds LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-09-02 — — US disclosed
US-20130102609-A1 BIARYL OXYACETIC ACID COMPOUNDS LIGAND PHARMACEUTICALS INC. (US) 2013-04-25 — — US disclosed
US-20130102609-A1 BIARYL OXYACETIC ACID COMPOUNDS LIGAND PHARMACEUTICALS INC. (US) 2013-04-25 — — US disclosed
US-20130102609-A1 BIARYL OXYACETIC ACID COMPOUNDS LIGAND PHARMACEUTICALS INC. (US) 2013-04-25 — — US disclosed
WO-2010102154-A2 BIARYL OXYACETIC ACID COMPOUNDS LIGAND PHARMACEUTICALS INCORPORATED (US) 2010-09-10 — — WO disclosed
WO-2010102154-A2 BIARYL OXYACETIC ACID COMPOUNDS LIGAND PHARMACEUTICALS INCORPORATED (US) 2010-09-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102609-A1 BIARYL OXYACETIC ACID COMPOUNDS HSD17B12, CYP2A13, CYP27A1 MAPT 4135/4885ACLY 1166/4885ALDH1A1 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.